A Phase II Neoadjuvant Trial of Sequential Doxorubicin and Docetaxel for the Treatment of Stage III Breast Cancer Measuring STAT Activation as a Predictor of Response to Therapy
Phase of Trial: Phase II
Latest Information Update: 24 Sep 2012
At a glance
- Drugs Docetaxel; Doxorubicin; Filgrastim
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 04 Sep 2005 New trial record.